Related Experiment Video
Updated: Jun 27, 2025

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
Formulation development, characterization, and evaluation of bedaquiline fumarate - Soluplus® - solid dispersion
Vishwas P Pardhi1, Manisha Patel1, Keerti Jain1
1Department of Pharmaceutics, Drug Delivery and Nanomedicine Research Laboratory, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, India.
Bedaquiline fumarate (BQF) solubility and bioavailability were enhanced using Soluplus-based solid dispersions. Ternary solid dispersions significantly improved BQF
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Biopharmaceutics
Background:
- Bedaquiline fumarate (BQF) exhibits poor water solubility and dissolution, limiting its bioavailability due to its BCS Class II classification.
- Previous studies utilized crystalline polymers like poloxamer 188 for BQF solid dispersions, showing moderate solubility improvements.
- Amorphous polymers offer potential advantages for enhancing the solubility of poorly soluble drugs.
Purpose of the Study:
- To enhance the biopharmaceutical properties of bedaquiline fumarate (BQF).
- To develop and characterize binary (BSD) and ternary solid dispersions (TSD) of BQF using Soluplus®.
- To evaluate the impact of Soluplus® on BQF solubility, dissolution, cellular uptake, and bioavailability.
Main Methods:
- Preparation of binary solid dispersions (BSD) and ternary solid dispersions (TSD) of BQF with Soluplus®.
- Solubility and dissolution studies comparing BQF, BSD, and TSD.
- Solid-state characterization (e.g., FTIR) and cellular uptake studies in Caco-2 cell lines.
- Pharmacokinetic evaluation of the developed solid dispersion formulations.
Main Results:
- Solubility of BQF increased by 14.31-fold in BSD and 20.43-fold in TSD compared to pure BQF.
- Soluplus® demonstrated superior solubility enhancement for BQF compared to poloxamer 188.
- Characterization confirmed the amorphous state of BQF within the solid dispersions without chemical interactions.
- Enhanced cellular uptake and significantly improved pharmacokinetic profiles, including bioavailability, were observed for TSDs.
Conclusions:
- Solid dispersions formulated with amorphous Soluplus® represent a promising strategy for improving BQF's biopharmaceutical performance.
- Ternary solid dispersions (TSD) show superior potential for enhancing BQF solubility and bioavailability.
- This formulation approach offers a viable solution for overcoming the bioavailability challenges associated with poorly soluble drugs like BQF.
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Influencing Drug Absorption: Drug Dissolution
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Biopharmaceutics and Pharmacokinetics: Overview
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...

